MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 02.03.2026
Nuvation Bio P/CF 2011-2026 | NUVB
P/CF Jährlich Nuvation Bio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.0115 | -0.00387 | -0.00608 | -0.00374 | -0.0177 | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.00374 | -0.0177 | -0.00858 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M |  USA |
 |
AbbVie
ABBV
|
21 | $ 209.63 | -0.71 % | $ 371 B | USA |
 |
Verastem
VSTM
|
-2.94 | $ 4.99 | -5.77 % | $ 346 M | USA |
 |
VistaGen Therapeutics
VTGN
|
-1.75 | $ 0.57 | -5.85 % | $ 17.6 M | USA |
 |
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | USA |
 |
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | USA |
 |
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | USA |
 |
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B |  France |
 |
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | USA |
 |
Voyager Therapeutics
VYGR
|
-1.82 | $ 3.96 | -4.24 % | $ 232 M | USA |
 |
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | France |
 |
Aileron Therapeutics
ALRN
|
-1.71 | - | 10.36 % | $ 9.8 M | USA |
 |
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | USA |
 |
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-12.5 | - | -6.81 % | $ 3.04 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | USA |
 |
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M |  Israel |
 |
Atreca
BCEL
|
-0.607 | - | -11.76 % | $ 5.79 M | USA |
 |
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | USA |
 |
bluebird bio
BLUE
|
-0.285 | - | - | $ 546 M | USA |
 |
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | Canada |
 |
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |  Russia |
 |
Avid Bioservices
CDMO
|
38.7 | - | - | $ 789 M | USA |
 |
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
-54 | $ 12.36 | -11.46 % | $ 1.88 B | USA |
 |
Wave Life Sciences Ltd.
WVE
|
-13.9 | $ 6.39 | 3.06 % | $ 1.08 B |  Singapore |
 |
Xenetic Biosciences
XBIO
|
-1.91 | $ 2.78 | -0.71 % | $ 4.73 M | USA |
 |
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B |  Cayman-islands |
|
XBiotech
XBIT
|
-1.76 | $ 2.27 | -1.73 % | $ 69.2 M | USA |
 |
Xenon Pharmaceuticals
XENE
|
-16.5 | $ 54.44 | -1.96 % | $ 4.24 B | Canada |
 |
Xeris Pharmaceuticals
XERS
|
33.8 | $ 5.41 | -2.87 % | $ 868 M | USA |
 |
X4 Pharmaceuticals
XFOR
|
-2.09 | $ 4.07 | -5.57 % | $ 172 M | USA |
 |
Xencor
XNCR
|
-6.6 | $ 11.4 | -7.43 % | $ 846 M | USA |
 |
XOMA Corporation
XOMA
|
115 | $ 29.93 | -1.97 % | $ 362 M | USA |
 |
22nd Century Group
XXII
|
-0.0701 | $ 2.41 | -18.03 % | $ 444 K | USA |
 |
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | USA |
 |
Cara Therapeutics
CARA
|
-0.588 | - | -3.03 % | $ 260 M | USA |
 |
ChemoCentryx
CCXI
|
-0.024 | - | - | $ 3.74 B | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
-1.4 | $ 1.06 | -2.75 % | $ 21.7 M | Israel |
 |
Enochian Biosciences
ENOB
|
-14.7 | - | - | $ 40.5 M | USA |